Visionary Holdings (GV)’ Visionary Health Technology continued execution progress under its previously signed commercial sales agreement with a total contract value of approximately $9M. The agreement, signed in September 2025, is currently in the implementation stage, with service activities underway. GV Hong Kong is working closely with its business partner to advance phased implementation efforts under the terms of the agreement. Since the signing of the agreement, both parties have continued to advance contractual milestones. Early-stage service activities remain in progress. Based on the current delivery schedule and client coordination progress, the Company expects the agreement to achieve further substantive execution milestones by the end of the first quarter of 2026. Any related revenue recognition and cash collection will be recorded in accordance with the terms of the agreement and applicable accounting standards.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GV:
- Visionary Holdings establishes three subsidiaries in Qingdao, Wuxi, Wuhu
- Visionary Holdings regains compliance with Nasdaq periodic filing rule
- Visionary Holdings Overhauls Governance and Seals Key Deals in Pivot to High-End Anti-Aging Aesthetics
- Visionary Holdings appoints Wenxuan Cai as CEO of GV Hong Kong
